Why PTC Stock Is Back in Focus After Earnings and New Client Win PTC (PTC) is back on many investors radar after a combination of better than expected quarterly results, higher full year guidance, and a fresh enterprise win for its FlexPLM software with SPG Company.

Shares in industrial software company PTC (NASDAQ: PTC) were lower by 8.8% in the week to Thursday afternoon. The move comes after a poorly received first-quarter 2025 earnings released on Wednesday. The headline numbers were superficially disappointing ...

PTC Inc. closed 30.32% short of its 52-week high of $219.69, which the company achieved on July 31st.

Investing.com -- PTC Inc (NASDAQ:PTC) stock fell 3.8% on Thursday after Google announced a major upgrade to its Gemini 3 Deep Think AI system, potentially challenging PTC’s position in the engineering software market.

We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this piece, we will look at where PTC Inc. (NASDAQ:PTC) ranks in the list. As the fourth quarter of 2024 settles in, the narrative ...

Shares of PTC Inc. PTC slid 5.21% to $153.48 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.11% to 49,071.56 and the S&P 500 Index SPX falling 0.13% to 6,969.01.

$20,000 of PTC INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "CoAspire is lobbying two activities for PTC Inc. for the Army and Navy in the FY26 NDAA and FY26 Defense ...

If you are looking at PTC Therapeutics and wondering whether the current share price gives you enough value for the risk, this breakdown is designed to help you answer that directly. The stock last closed at US$69.